CAR T and Other Options for Relapsed/Refractory Follicular Lymphoma: Javier L. Munoz, MD, MS, FACP
The director of Mayo Clinic's Lymphoma Program discussed R/R FL and current treatment options.
This content originally appeared on our sister site, CancerNetwork.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Recent Videos
Related Content
